Silencing of the PHLDA1 leads to global proteome changes and differentiation pathways of human neuroblastoma cells.

{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:38495105", "kind": "science-record", "revision": 3, "content_hash": "sha256:cabaad27cb165911cbc7930b7472a1d2f892417f3ada6ed95083496dd1d82835", "created_at": "2026-11-01T19:20:26Z", "updated_at": "2026-11-01T21:32:43Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Silencing of the PHLDA1 leads to global proteome changes and differentiation pathways of human neuroblastoma cells.", "doi": "10.3389/fphar.2024.1351536", "pmid": "38495105", "authors": ["Beata Bugara", "Małgorzata Durbas", "Maja Kudrycka", "Agata Malinowska", "Irena Horwacik", "Hanna Rokita"], "journal": "Frontiers in pharmacology", "year": 2024, "abstract": "Neuroblastoma (NB) is the most common extracranial pediatric solid tumor originating from the abnormal development of cells of the sympathoadrenal lineage of the neural crest. Targeting GD2 ganglioside (GD2), a glycolipid expressed on neuroblastoma cells, with GD2 ganglioside-recognizing antibodies affects several pivotal signaling routes that drive or influence the malignant phenotype of the cells. Previously performed gene expression profiling helped us to identify the PHLDA1 (pleckstrin homology-like domain family A member 1) gene as the most upregulated gene in the IMR-32 human neuroblastoma cells treated with the mouse 14G2a monoclonal antibody. Mass spectrometry-based proteomic analyses were applied to better characterize a role of PHLDA1 protein in the response of neuroblastoma cells to chimeric ch14.18/CHO antibody. Additionally, global protein expression profile analysis in the IMR-32 cell line with PHLDA1 silencing revealed the increase in biological functions of mitochondria, accompanied by differentiation-like phenotype of the cells. Moreover, mass spectrometry analysis of the proteins co-immunoprecipitated using anti-PHLDA1-specific antibody, selected a group of possible PHLDA1 binding partners. Also, a more detailed analysis suggested that PHLDA1 interacts with the DCAF7/AUTS2 complex, a key component of neuronal differentiation in vitro. Importantly, our results indicate that PHLDA1 silencing enhances the EGF receptor signaling pathway and combinatory treatment of gefitinib and ch14.18/CHO antibodies might be beneficial for neuroblastoma patients. Data are available via ProteomeXchange with the identifier PXD044319.", "claims": [{"id": "claim-method", "statement": "Four experimental conditions in two repetitions were studied for co-IP semi-quantitative analysis, based on sample/control ratios without further statistical steps. For shPHLDA1/shCtrl quantification, five replicates per group were employed, with two-sample t-test and permutation-based FDR to establish statistical significance.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38495105", "locator": "sections[16] \"2.14 Statistical rationale\" paragraph 2", "quote": "Four experimental conditions in two repetitions were studied for co-IP semi-quantitative analysis, based on sample/control ratios without further statistical steps. For shPHLDA1/shCtrl quantification, five replicates per group were employed, with two-sample t-test and permutation-based FDR to establish statistical significance."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material. Data are available via ProteomeXchange (https://www.ebi.ac.uk/pride/), with the identifier PXD044319.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38495105", "locator": "sections[30] \"Data availability statement\" paragraph 2", "quote": "The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material. Data are available via ProteomeXchange (https://www.ebi.ac.uk/pride/), with the identifier PXD044319."}], "state": "complete"}, {"id": "claim-target-result", "statement": "Importantly, our results indicate that PHLDA1 silencing enhances the EGF receptor signaling pathway and combinatory treatment of gefitinib and ch14.18/CHO antibodies might be beneficial for neuroblastoma patients.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:38495105", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Importantly, our results indicate that PHLDA1 silencing enhances the EGF receptor signaling pathway and combinatory treatment of gefitinib and ch14.18/CHO antibodies might be beneficial for neuroblastoma patients."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "Importantly, our results indicate that PHLDA1 silencing enhances the EGF receptor signaling pathway and combinatory treatment of gefitinib and ch14.18/CHO antibodies might be beneficial for neuroblastoma patients.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:38495105"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD044319"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD044319"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:38495105", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fphar.2024.1351536", "sha256": "sha256:bd445e1ac1c42a83cb6a5cd80a7d1f92b78d85a398301ebf2850c5057866d5ee", "bytes": 62027, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fphar.2024.1351536", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC10941682", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD044319", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD044319", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD044319", "version": null, "note": "The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material. Data are available via ProteomeXchange (https://www.ebi.ac.uk/pride/), with the identifier PXD044319.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material. Data are available via ProteomeXchange (https://www.ebi.ac.uk/pride/), with the identifier PXD044319.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "Silencing of the PHLDA1 leads to global proteome changes and differentiation pathways of human neuroblastoma cells", "resolution_checked_at": "2026-11-01T20:16:17Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:PXD044319 not downloaded", "asset:data:geo:PXD044319 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "For co-IP semi-quantitative analysis, sample/control ratios were used without further statistical steps; for shPHLDA1/shCtrl quantification, a two-sample t-test with permutation-based FDR was used.", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Four experimental conditions in two repetitions were studied for co-IP semi-quantitative analysis, based on sample/control ratios without further statistical steps. For shPHLDA1/shCtrl quantification, five replicates per group were employed, with two-sample t-test and permutation-based FDR to establish statistical significance."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (For co-IP semi-quantitative analysis, sample/control ratios were used without further statistical steps; for shPHLDA1/shCtrl quantification, a two-sample t-test with permutation-based FDR was used.), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD044319"], "resolved_accessions": ["PXD044319"], "statements": ["The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material. Data are available via ProteomeXchange (https://www.ebi.ac.uk/pride/), with the identifier PXD044319."], "basis": "The paper names PXD044319 in ProteomeXchange and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:38495105", "data:geo:PXD044319"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD044319"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:12:24Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 17297, "completion_tokens": 2013, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:38495105", "type": "paper", "label": "pmid:38495105"}, {"id": "source:pmid:38495105", "type": "manuscript", "label": "PMID 38495105 full text"}, {"id": "data:geo:PXD044319", "type": "dataset", "label": "GEO PXD044319"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:38495105", "type": "paper", "label": "pmid:38495105"}, {"id": "source:pmid:38495105", "type": "manuscript", "label": "PMID 38495105 full text"}, {"id": "data:geo:PXD044319", "type": "dataset", "label": "GEO PXD044319"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-38495105", "type": "extraction", "used": ["source:pmid:38495105"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD044319", "type": "accession_resolution", "used": ["data:geo:PXD044319"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:38495105", "parent_hash": "sha256:011782fd47955c913154818955f81f89b6b5d8d4dc381feb12fe8a8439d57288", "fork_of": null, "generation": 2}, "gaps": ["asset:data:geo:PXD044319 licence not read", "asset:data:geo:PXD044319 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "animal_model", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.69, "evidence": ["2 human neuroblastoma cells treated with the mouse 14G2a monoclonal antibody. Mass spectrometry"], "order_basis": "paper_text_order:697", "id": "assay:1"}, {"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ed with the mouse 14G2a monoclonal antibody. Mass spectrometry-based proteomic analyses were applied to bet", "ation-like phenotype of the cells. Moreover, mass spectrometry analysis of the proteins co-immunoprecipitat", "tamicin at 37 °C in a 5% CO2 atmosphere. 2.3 Mass spectrometry analysis of proteins co-immunoprecipitated w", "was performed by LC-MS in the Laboratory of Mass Spectrometry (IBB PAS, Warsaw) using a nanoAcquity UPLC s"], "order_basis": "paper_text_order:730", "id": "assay:2"}, {"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.77, "evidence": ["ma cells (ATCC, United States, CCL-127) were cultured in Eagle’s minimum essential medium (EMEM) supp"], "order_basis": "paper_text_order:1840", "id": "assay:3"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["f neuroblastoma patients we re-analyzed mRNA microarray results of Tumor Neuroblastoma SEQC dataset"], "order_basis": "paper_text_order:9299", "id": "assay:4"}]}